Budapest, Hungary

László Ugrai

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Egis Gyogyszergyar Zrt.. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: László Ugrai. Retrieved from https://idiyas.com/inventor/lászló-ugrai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: László Ugrai: Innovator in Pharmaceutical Composition

Introduction

László Ugrai is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions that enhance treatment efficacy.

Latest Patents

Ugrai holds a patent for a pharmaceutical composition containing palbociclib and letrozole. This composition features palbociclib tosylate and letrozole in a single dosage unit, ensuring that the active ingredients are not separated from each other. The patent also covers the production of the pharmaceutical preparation, which includes granules containing both active ingredients, as well as special blister packaging designed to facilitate a specific dosage regimen.

Career Highlights

László Ugrai is associated with Egis Gyógyszergyár Zrt., a prominent pharmaceutical company in Hungary. His work at Egis has allowed him to focus on developing innovative solutions that address critical health challenges.

Collaborations

Ugrai collaborates with Gyula Lukács, a fellow professional in the pharmaceutical field. Their partnership exemplifies the collaborative spirit that drives innovation in the industry.

Conclusion

László Ugrai's contributions to pharmaceutical compositions demonstrate his commitment to advancing medical science. His innovative work continues to impact the field positively, showcasing the importance of collaboration and creativity in developing effective treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…